These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Ribozymes in the age of molecular therapeutics. Bagheri S; Kashani-Sabet M Curr Mol Med; 2004 Aug; 4(5):489-506. PubMed ID: 15267221 [TBL] [Abstract][Full Text] [Related]
7. Ribozymes: killing the messenger. Barinaga M Science; 1993 Dec; 262(5139):1512-4. PubMed ID: 8248799 [No Abstract] [Full Text] [Related]
8. Designing and characterizing hammerhead ribozymes for use in AAV vector-mediated retinal gene therapies. Fritz JJ; White DA; Lewin AS; Hauswirth WW Methods Enzymol; 2002; 346():358-77. PubMed ID: 11883079 [No Abstract] [Full Text] [Related]
9. The therapeutic potential of ribozymes. James HA; Gibson I Blood; 1998 Jan; 91(2):371-82. PubMed ID: 9427689 [TBL] [Abstract][Full Text] [Related]
10. Design and testing of ribozymes for cancer gene therapy. Norris JS; Hoel B; Voeks D; Maggouta F; Dahm M; Pan W; Clawson G Adv Exp Med Biol; 2000; 465():293-301. PubMed ID: 10810634 [TBL] [Abstract][Full Text] [Related]
13. Application of preformed hammerhead ribozymes in the gene therapy of cancer (review). Sioud M Int J Mol Med; 1999 Apr; 3(4):381-4. PubMed ID: 10085409 [TBL] [Abstract][Full Text] [Related]
14. The potential application of ribozymes for the treatment of hematological disorders. James HA J Leukoc Biol; 1999 Sep; 66(3):361-8. PubMed ID: 10496304 [TBL] [Abstract][Full Text] [Related]
15. Ribozymes. Their design and use in cancer. Turner PC Adv Exp Med Biol; 2000; 465():303-18. PubMed ID: 10810635 [No Abstract] [Full Text] [Related]
17. Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses. Alvarez-Salas LM; Benítez-Hess ML; DiPaolo JA Antivir Ther; 2003 Aug; 8(4):265-78. PubMed ID: 14518695 [TBL] [Abstract][Full Text] [Related]
18. Development of ribozymes for gene therapy. Sullivan SM J Invest Dermatol; 1994 Nov; 103(5 Suppl):85S-89S. PubMed ID: 7963690 [TBL] [Abstract][Full Text] [Related]
19. Engineered ribozymes as molecular tools for site-specific alteration of RNA sequence. Müller S Chembiochem; 2003 Oct; 4(10):991-7. PubMed ID: 14523916 [No Abstract] [Full Text] [Related]
20. Ribozymes: use as anti-HIV therapeutic molecules. Dropulic B; Elkins DA; Rossi JJ; Sarver N Antisense Res Dev; 1993; 3(1):87-94. PubMed ID: 8495108 [No Abstract] [Full Text] [Related] [Next] [New Search]